Raymond James & Associates’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$1.7M Buy
21,162
+4,211
+25% +$338K ﹤0.01% 2315
2024
Q2
$1.4M Buy
16,951
+7,979
+89% +$660K ﹤0.01% 2376
2024
Q1
$766K Sell
8,972
-15,078
-63% -$1.29M ﹤0.01% 2759
2023
Q4
$2.06M Sell
24,050
-8,751
-27% -$748K ﹤0.01% 2074
2023
Q3
$2.94M Buy
32,801
+3,421
+12% +$306K ﹤0.01% 1780
2023
Q2
$2.5M Sell
29,380
-18,745
-39% -$1.6M ﹤0.01% 1907
2023
Q1
$3.98M Buy
48,125
+31,745
+194% +$2.63M ﹤0.01% 1623
2022
Q4
$1.29M Buy
16,380
+4,226
+35% +$332K ﹤0.01% 2281
2022
Q3
$900K Sell
12,154
-17,104
-58% -$1.27M ﹤0.01% 2463
2022
Q2
$1.91M Sell
29,258
-39,190
-57% -$2.55M ﹤0.01% 2010
2022
Q1
$4.33M Buy
68,448
+13,791
+25% +$872K ﹤0.01% 1608
2021
Q4
$2.9M Buy
+54,657
New +$2.9M ﹤0.01% 1906
2021
Q3
Sell
-10,295
Closed -$686K 3988
2021
Q2
$686K Sell
10,295
-9,240
-47% -$616K ﹤0.01% 2840
2021
Q1
$2.17M Buy
19,535
+54
+0.3% +$6K ﹤0.01% 1952
2020
Q4
$2.31M Buy
19,481
+1,042
+6% +$124K ﹤0.01% 1801
2020
Q3
$1.61M Buy
18,439
+14,738
+398% +$1.29M ﹤0.01% 1893
2020
Q2
$331K Sell
3,701
-6,539
-64% -$585K ﹤0.01% 2844
2020
Q1
$1.02M Sell
10,240
-28,221
-73% -$2.81M ﹤0.01% 1961
2019
Q4
$4.42M Sell
38,461
-3,838
-9% -$441K 0.01% 1333
2019
Q3
$5.34M Buy
42,299
+33,611
+387% +$4.24M 0.01% 1185
2019
Q2
$1.05M Sell
8,688
-1,427
-14% -$172K ﹤0.01% 2182
2019
Q1
$885K Sell
10,115
-601
-6% -$52.6K ﹤0.01% 2276
2018
Q4
$1.07M Buy
10,716
+4,632
+76% +$463K ﹤0.01% 2050
2018
Q3
$697K Sell
6,084
-1,721
-22% -$197K ﹤0.01% 2472
2018
Q2
$700K Buy
7,805
+4,345
+126% +$390K ﹤0.01% 2444
2018
Q1
$253K Buy
+3,460
New +$253K ﹤0.01% 2986